Platinum-Resistant Ovarian Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08885 | Aflibercept | 1 | Active Not Recruiting | 1 |
DB00062 | Albumin human | 1 | Active Not Recruiting | 1 |
DB17450 | Albumin-stabilized nanoparticle (130 nm) | 1 | Active Not Recruiting | 1 |
DB00041 | Aldesleukin | 1 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 1 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 1 | Active Not Recruiting | 1 |
DB14547 | Chloride ion | 1 | Active Not Recruiting | 1 |
DB00515 | Cisplatin | 1 | Active Not Recruiting | 1 |
DB12483 | Copanlisib | 1 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
DB00997 | Doxorubicin | 1 | Active Not Recruiting | 1 |
DB01073 | Fludarabine | 1 | Recruiting | 1 |
DB00441 | Gemcitabine | 1 | Active Not Recruiting | 2 |
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB00888 | Mechlorethamine | 1 | Active Not Recruiting | 1 |
DB11793 | Niraparib | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 1 | Completed | 1 |
DB06306 | Onalespib | 1 | Completed | 1 |
DB01229 | Paclitaxel | 1 | Active Not Recruiting | 2 |
DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
DB12257 | Platinum | 1 | Active Not Recruiting | 1 |
DB00759 | Tetracycline | 1 | Active Not Recruiting | 1 |
DB11595 | Atezolizumab | 1 / 2 | Active Not Recruiting | 1 |
DB17522 | Batiraxcept | 1 / 2 | Active Not Recruiting | 1 |
DB11059 | Carboxymethylcellulose | 1 / 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Active Not Recruiting | 1 |
DB01262 | Decitabine | 1 / 2 | Active Not Recruiting | 1 |
DB11714 | Durvalumab | 1 / 2 | Active Not Recruiting | 1 |
DB11918 | Guadecitabine | 1 / 2 | Active Not Recruiting | 1 |
DB17293 | Hiltonol | 1 / 2 | Active Not Recruiting | 1 |
DB17107 | Lifileucel | 1 / 2 | Active Not Recruiting | 1 |
DB00123 | Lysine | 1 / 2 | Active Not Recruiting | 1 |
DB11793 | Niraparib | 1 / 2 | Not Yet Recruiting | 1 |
DB15185 | Rasdegafusp alfa | 1 / 2 | Active Not Recruiting | 1 |
DB11135 | Selenium | 1 / 2 | Not Yet Recruiting | 1 |
DB00041 | Aldesleukin | 2 | Active Not Recruiting | 1 |
DB14809 | Anetumab ravtansine | 2 | Active Not Recruiting | 1 |
DB01117 | Atovaquone | 2 | Recruiting | 1 |
DB11105 | Benzalkonium | 2 | Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Active Not Recruiting | 2 |
DB00112 | Bevacizumab | 2 | Completed | 1 |
DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 2 |
DB14844 | Dordaviprone | 2 | Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Active Not Recruiting | 1 |
DB11714 | Durvalumab | 2 | Recruiting | 1 |
DB01073 | Fludarabine | 2 | Active Not Recruiting | 2 |
DB00441 | Gemcitabine | 2 | Active Not Recruiting | 1 |
DB14865 | Human interleukin-2 | 2 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
DB00762 | Irinotecan | 2 | Completed | 1 |
DB09078 | Lenvatinib | 2 | Active Not Recruiting | 1 |
DB17107 | Lifileucel | 2 | Active Not Recruiting | 2 |
DB10315 | Measles virus vaccine live attenuated | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 3 |
DB01229 | Paclitaxel | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
DB05482 | SN-38 | 2 | Recruiting | 1 |
DB11119 | Sodium iodide | 2 | Active Not Recruiting | 1 |
DB15389 | Teceleukin | 2 | Active Not Recruiting | 1 |
DB00759 | Tetracycline | 2 | Active Not Recruiting | 1 |
DB01030 | Topotecan | 2 | Active Not Recruiting | 1 |
DB11771 | Tremelimumab | 2 | Recruiting | 1 |